Illness-centered identities can drive markets for unproven, risky treatments via advocacy and community dynamics.
— Raises consumer protection and regulatory oversight questions for healthcare services and misinformation.
Jesse Singal
2025.08.07
100% relevant
It notes chronic Lyme communities and exposure to dangerous experimental treatments as a cautionary analog.
← Back to All Ideas